Page last updated: 2024-08-24

telmisartan and Bleeding

telmisartan has been researched along with Bleeding in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Akagi, Y; Aoyama, T; Enomoto, A; Hoshiko, M; Kawano, Y; Kujirai, A; Mano, Y; Nagata, M; Nakamatsu, S; Nakamura, S; Negishi, K; Nishikawa, T; Shimada, S; Suzuki, T; Tsukada, E	1
Kent, DM; Thaler, DE	1
Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S	1

Trials

1 trial(s) available for telmisartan and Bleeding

Article	Year
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Vascular Diseases	2008

Article

Year

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12

Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Vascular Diseases

2008

Other Studies

2 other study(ies) available for telmisartan and Bleeding

Article	Year
Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:5 Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B; Bisoprolol; Case-Control Studies; Drug Interactions; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Telmisartan; Warfarin	2021
Stroke prevention--insights from incoherence. The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine	2008

Article

Year

Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users.

Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:5

Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B; Bisoprolol; Case-Control Studies; Drug Interactions; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Telmisartan; Warfarin

2021

Stroke prevention--insights from incoherence.

The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12

Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine

2008